https://www.biodesix.com/newsroom/press-releases/biodesix-selected-to-present-at-multi-state-investor-and-partnering-conference2021-10-25https://www.biodesix.com/newsroom/press-releases/genestrat-liquid-biopsy-test-earns-approval-ny-state-clep2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-initiates-biomarker-study2020-12-23https://www.biodesix.com/newsroom/news/veristrat-passes-phase-3-trial-xconomy2023-12-12https://www.biodesix.com/newsroom/blog/nodify-xl2-lung-nodule-video2021-10-25https://www.biodesix.com/newsroom/press-releases/veristrat-test-results-correlate-with-survival-outcomes-in-advanced-lung-cancer2019-09-05https://www.biodesix.com/newsroom/press-releases/biodesix-to-present-three-blood-based-diagnostic-studies-aacr-annual-meeting2020-11-16https://www.biodesix.com/newsroom/press-releases/veristrat-test-identifies-lung-cancer-patients-benefiting-from-combination-therapy2019-09-05https://www.biodesix.com/newsroom/news/test-targets-rocheosi-drug-reuters2020-11-13https://www.biodesix.com/newsroom/press-releases/biodesix-secures-medicare-coverage-for-veristrat-test2019-09-05https://www.biodesix.com/webinar-santos2020-11-02https://www.biodesix.com/about/our-team/steve-springmeyer-md2020-08-11https://www.biodesix.com/newsroom/press-releases/biodesix-bcd2023-12-13https://www.biodesix.com/newsroom/press-releases/biodesix-announces-presentation-on-novel-proteomic-techniques-in-partnership-with-seer2022-12-09https://www.biodesix.com/newsroom/news/nsclc-outcomes-with-proteomic-test2020-11-13https://www.biodesix.com/newsroom/news/anti-pd1-lung-cancer-immunotherapy2021-12-17https://www.biodesix.com/wclc2020-abstract32021-01-21https://www.biodesix.com/newsroom/press-releases/biodesix-announces-preliminary-revenue-for-third-quarter-20222022-10-13https://www.biodesix.com/newsroom/news/liquid-biopsy-test-ros1ret-available2020-11-13https://www.biodesix.com/newsroom/press-releases/biodesix-nodify-cdt2023-12-13https://www.biodesix.com/wclc2020-abstract22021-01-20https://www.biodesix.com/newsroom/press-releases/biodesix-closes-series-d-financing2022-10-28https://www.biodesix.com/newsroom/press-releases/biodesix-highlights-pipeline-and-companion-diagnostic-development2022-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-announces-pricing-of-35.1-million-upsized-public-offering-of-common-stock2022-11-17https://www.biodesix.com/newsroom/press-releases/advanced-diagnostic-tests-including-veristrat-can-help-physicians-improve-cancer-care2020-11-16https://www.biodesix.com/newsroom/news/new-collaboration-lung-cancer-detection2021-10-25https://www.biodesix.com/newsroom/press-releases/biodesix-serology-test-antibodies2020-05-19https://www.biodesix.com/thank-you-asco2021-05-25https://www.biodesix.com/newsroom/press-releases/blood-based-diagnostic-assay-measures-immunotherapy-biomarker-pd-l12019-09-21https://www.biodesix.com/newsroom/press-releases/biomarker-research2019-09-05https://www.biodesix.com/newsroom/press-releases/biodesix-announces-publication-further-validating-the-use-of-liquid-biopsies-and-ngs-techniques-to-provide-clinical-information-for-patie-16484877476982023-01-26https://www.biodesix.com/newsroom/press-releases/biodesix-announces-presentation-on-sars-cov-2-neutralizing-antibody-testing-for-individual-vaccine-response-and-commercial-launch-plans2021-10-25https://www.biodesix.com/resources/video-how-nodify-works2021-03-29https://www.biodesix.com/newsroom/press-releases/biodesix-paul-beresford-joins-2012-bio-panel-for-personalized-medicine-commercialization2019-12-09https://www.biodesix.com/newsroom/press-releases/veristrat-differential-treatment-benefit-chemotherapy-targeted-therapy-lung-cancer-patients2020-11-16https://www.biodesix.com/resources/video/biodesix-seer-webinar2021-06-23https://www.biodesix.com/resources/using-biomarker-based-risk-assessments-to-inform-lung-nodule-referral-decisions2021-06-30https://www.biodesix.com/newsroom/press-releases/biodesix-and-capital-royalty-close-financing-transaction2019-09-05https://www.biodesix.com/newsroom/news/blood-test-may-help-fight-lung-cancer2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-to-report-third-quarter-2022-financial-results-on-nov.-3-20222023-01-26https://www.biodesix.com/newsroom/press-releases/200-million-americans-now-insurance-coverage-biodesix-veristrat-test2019-09-05https://www.biodesix.com/thank-you-nodify2021-05-12https://www.biodesix.com/our-purpose/our-team/james-jett-md2023-12-12https://www.biodesix.com/newsroom/blog/lung-nodules-understanding-the-basics-and-navigating-the-path-forward2023-12-13https://www.biodesix.com/newsroom/news/nature-technology-for-proteomic-age2022-12-07https://www.biodesix.com/newsroom/press-releases/chest-panoptic2021-11-22https://www.biodesix.com/newsroom/news/biodesix-wins-iq-award2020-11-13https://www.biodesix.com/newsroom/press-releases/biodesix-receives-highmark-blue-cross-blue-shield-coverage-for-veristrat-test2019-12-09https://www.biodesix.com/newsroom2023-11-09https://www.biodesix.com/newsroom/press-releases/biodesix-announces-fourth-quarter-and-fiscal-year-end-2022-results-and-highlights2023-03-06https://www.biodesix.com/careers/benefits2023-03-10https://www.biodesix.com/newsroom/press-releases/biodesix-announces-abstracts-presented-during-the-iaslc-2021-world-conference-on-lung-cancer2021-11-22https://www.biodesix.com/newsroom/press-releases/asco-alcmi-bdsx-beacon-lung2021-05-26https://www.biodesix.com/newsroom/press-releases/biodesix-ceo-to-present-at-personalized-medicine-partnerships-conference2019-12-09https://www.biodesix.com/newsroom/press-releases/presentation-canaccord-genuity-virtual-medtech-diagnostics-digital-health-services-forum2022-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-to-deliver-sequencing-assay-for-blood-based-companion-diagnostic-solutions-in-cancer2021-12-17https://www.biodesix.com/about/our-team/james-jett-md2020-08-12https://www.biodesix.com/newsroom/press-releases/biodesix-announces-senior-secured-financing-agreement-with-perceptive-advisors-for-up-to-50-million2022-11-17https://www.biodesix.com/newsroom/press-releases/biodesix-partners-with-mll2022-12-09https://www.biodesix.com/newsroom/press-releases/new-data-demonstrate-veristrat-test-reliably-informs-lung-cancer-treatment-decisions2019-12-09https://www.biodesix.com/newsroom/press-releases/biognosys-proteomics2021-09-29https://www.biodesix.com/newsroom/news/challenges-liquid-biopsy2020-11-13https://www.biodesix.com/wclc2020-abstract12021-01-20https://www.biodesix.com/newsroom/blog/performance-blood-based-test2021-11-22https://www.biodesix.com/newsroom/press-releases/biodesix-announces-pd-l1-collaboration-with-professor-fred-r-hirsch-md-phd2021-12-17https://www.biodesix.com/newsroom/news/bio2012-fiercebiomarkers2020-11-13https://www.biodesix.com/newsroom/events/aacr-20192019-09-12https://www.biodesix.com/newsroom/press-releases/biodesix-desoto-laboratory-receives-both-iso-134852016-certification-and-accreditation-from-the-college-of-american-pathologists2021-10-25https://www.biodesix.com/newsroom/press-releases/presentation-at-molecular-med-tri-conference-blood-based-cancer-immunotherapy-diagnostics2020-11-16https://www.biodesix.com/newsroom/news/getting-personal-clinical-lab-products2019-09-11https://www.biodesix.com/about/our-team/david-brunel2020-01-02https://www.biodesix.com/newsroom/press-releases/biodesix-appoints-vice-president-of-clinical-development-medical-affairs2019-09-05https://www.biodesix.com/patients/covid-19/instruction-video-spanish2021-09-30https://www.biodesix.com/newsroom/news/biodesix-new-acquisition2021-10-25https://www.biodesix.com/wclc20202021-01-28https://www.biodesix.com/newsroom/press-releases/biodesix-raises-follow-series-f-financing2019-09-05https://www.biodesix.com/about/our-team/jim-purvis2020-08-12https://www.biodesix.com/newsroom/blog/andrew-mcpherson-a-beacon-of-strength-in-the-fight-against-lung-cancer2023-11-29https://www.biodesix.com/gdpr2024-02-05https://www.biodesix.com/newsroom/news/pathologist-tobacco-belt2020-11-13https://www.biodesix.com/newsroom/press-releases/additional-data-in-phase-iii-lung-cancer-diagnostic-study2022-12-09https://www.biodesix.com/newsroom/blog/lung-nodules-and-lung-cancer-early-detection-how-to-advocate-for-yourself2023-12-18https://www.biodesix.com/newsroom/press-releases/biodesix-partners-boulder-community-health2020-05-20https://www.biodesix.com/newsroom/news/liquid-biopsy-tests-for-nsclc2020-11-13https://www.biodesix.com/newsroom/press-releases/biodesix-issued-four-additional-u-s-patents-for-blood-based-oncology-tests2019-09-05https://www.biodesix.com/our-tests/nodify-lung2022-12-07https://www.biodesix.com/contact-unsubscribe2021-04-01https://www.biodesix.com/newsroom/press-releases/veristrat-helps-oncologists-personalize-therapy-for-elderly-lung-cancer-patients2020-11-16https://www.biodesix.com/newsroom/news/coverage-for-biodesix-veristrat-test2022-10-28https://www.biodesix.com/chest20212021-11-02https://www.biodesix.com/newsroom/press-releases/robin-harper-cowie-appointed-to-colorado-bioscience-associations-board-of-directors2023-12-13https://www.biodesix.com/newsroom/press-releases/biodesix-participates-in-canaccord-genuity-annual-growth-conference2023-08-01https://www.biodesix.com/newsroom/press-releases/biodesix-to-present-new-data-on-nodify-lung-testing-at-chest-2023-annual-meeting2023-12-13https://www.biodesix.com/contact2024-01-08https://www.biodesix.com/newsroom/press-releases/biodesix-purdue-partnership2021-01-11https://www.biodesix.com/newsroom/press-releases/biodesix-announces-fourth-quarter-and-year-end-2021-results-and-highlights2022-08-03https://www.biodesix.com/patents2020-09-21https://www.biodesix.com/newsroom/news/the-future-is-fluid2021-10-25https://www.biodesix.com/newsroom/press-releases/biodesix-names-dr-james-jett2021-11-22https://www.biodesix.com/newsroom/press-releases/biodesix-announces-the-launch-of-its-genestrat-ngs-test-and-the-iqlung-testing-strategy-with-unprecedented-time-to-results2022-12-09https://www.biodesix.com/newsroom/press-releases/study-changes-in-veristrat-status-over-course-of-treatment-with-gefitinib-journal-of-thoracic-oncology2020-11-16https://www.biodesix.com/our-purpose/our-team/jessica-olbricht2024-01-08https://www.biodesix.com/technologies2022-12-07https://www.biodesix.com/newsroom/press-releases/biodesix-announces-presentation-of-new-nodify-xl2-data-at-aabip-conference-highlighting-increased-proportion-of-biopsies-diagnosing-cancer2023-08-22https://www.biodesix.com/newsroom/press-releases/biodesix-announces-key-patent-for-serum-test2020-11-13https://www.biodesix.com/newsroom/blog/case-study-monitoring-for-egfr2021-10-25https://www.biodesix.com/newsroom/news/better-route-for-diagnostics2020-11-13https://www.biodesix.com/newsroom/press-releases/biodesix-merck-pfizer2022-12-09https://www.biodesix.com/newsroom/press-releases/independent-study-clinical-use-biodesix-blood-based-tests-presented-chest-conference2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-announces-third-quarter-2020-results2021-01-08https://www.biodesix.com/newsroom/news/liquid-biopsy2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-and-inivata-next-generation-sequencing-blood-based-tests-for-advanced-patients2020-11-16https://www.biodesix.com/coesummit20212021-09-28https://www.biodesix.com/contact-nodify-brochure2021-06-16https://www.biodesix.com/newsroom/press-releases/prognostic-cancer-care-planning-value-veristrat-proteomic-managed-care2020-11-16https://www.biodesix.com/aabip20212021-08-19https://www.biodesix.com/newsroom/news/genomics-drives-veristrat-adoption2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-presenting-results-three-studies-sitc-annual-meeting2020-11-16https://www.biodesix.com/resources/lung-nodule-video2020-01-15https://www.biodesix.com/our-tests2023-03-01https://www.biodesix.com/newsroom/press-releases/biodesix-partners-with-chicago-public-schools-for-covid-19-testing-to-safely-reopen-schools2021-02-16https://www.biodesix.com/terms-conditions2024-03-18https://www.biodesix.com/newsroom/press-releases/biodesix-announces-impactful-clinical-data-on-the-primary-immune-response-pir-test-at-the-iaslc-2022-therapies-of-lung-cancer-meeting2022-03-03https://www.biodesix.com/newsroom/news/effectiveness-anti-pd-l1-therapy2021-11-22https://www.biodesix.com/newsroom/events/precision-lbx-20192019-09-12https://www.biodesix.com/newsroom/press-releases/biodesix-to-report-second-quarter-2023-financial-results-on-august-7-20232023-12-13https://www.biodesix.com/newsroom/press-releases/biodesix-nicholas-dupuis-ph-d-speaking-msacl-3rd-annual-conference2019-09-21https://www.biodesix.com/newsroom/news/test-boosts-nsclc-survival2020-11-13https://www.biodesix.com/newsroom/press-releases/data-supporting-clinical-use-biodesix-blood-tests2019-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-receives-2011-north-american-cancer-diagnostics-product-differentiation-excellence-award2019-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-to-participate-in-two-upcoming-investor-conferences-in-september-12023-12-13https://www.biodesix.com/newsroom/press-releases/osimertinib-resistance-precision-of-liquid-biopsy-aacr2022-10-27https://www.biodesix.com/newsroom/press-releases/biodesix-data-sitc-annual-meeting2019-09-05https://www.biodesix.com/newsroom/news/veristrat-prognostic-capabilities2021-10-25https://www.biodesix.com/newsroom/news/a-test-to-go-with-it-genomeweb2019-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-pipeline-test2021-11-22https://www.biodesix.com/newsroom/press-releases/biodesix-announces-third-quarter-2022-results-and-highlights2022-11-08https://www.biodesix.com/newsroom/press-releases/biodesix-raises-follow-on-series-e-financing2022-10-31https://www.biodesix.com/newsroom/press-releases/new-data-demonstrates-analytic-validity-of-automated-rna-extraction-genestrat2021-09-29https://www.biodesix.com/newsroom/press-releases/biodesix-to-participate-in-two-february-conferences2021-02-12https://www.biodesix.com/newsroom/news/immodulon-adopts-ai-for-clinical-trial2021-10-25https://www.biodesix.com/newsroom/press-releases/biodesix-presents-data-aacr-annual-meeting2019-09-05https://www.biodesix.com/newsroom/press-releases/society-for-advanced-bronchoscopy-meets-may-20-to-address-hot-topics-in-advanced-bronchoscopy2021-10-25https://www.biodesix.com/newsroom/news/genestrat-test-for-advanced-lung-cancer2023-12-12https://www.biodesix.com/our-purpose/our-team/chris-vazquez2024-01-08https://www.biodesix.com/newsroom/press-releases/paul-j-beresford-named-vice-president-business-development-and-stategic-marketing2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-data-aacr-annual-meeting-20172019-09-05https://www.biodesix.com/newsroom/events/precision-lbx-20202020-01-14https://www.biodesix.com/newsroom/press-releases/biodesix-receives-ce-mark-for-veristrat-specimen-collection-and-shipping-kit2019-09-05https://www.biodesix.com/resources/webinar-replay-hestia-6-252020-06-26https://www.biodesix.com/newsroom/news/cbsa-biobreakfast-rocky-radar2021-12-17https://www.biodesix.com/our-purpose/our-team/matthew-pink2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-test-predicts-response-to-atezolizumab-in-lung-cancer2019-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-worksafe-testing-program2021-09-29https://www.biodesix.com/newsroom/press-releases/biodesix-presents-ats-asco2020-05-27https://www.biodesix.com/newsroom/news/pd-l1-immunohistochemistry2023-12-12https://www.biodesix.com/resources/clinical-trials/thank-you2019-12-05https://www.biodesix.com/newsroom/news/serum-profiling-genetic-engineering-news2023-12-12https://www.biodesix.com/newsroom/blog/celebrating-cabrini-day-a-reflection-on-service-community-and-purpose2023-10-02https://www.biodesix.com/webinar-cancer-cant-wait2020-11-23https://www.biodesix.com/newsroom/press-releases/biodesix-awarded-advanced-diagnostic-laboratory-test-status-for-its-nodify-cdt-test-by-the-center-for-medicare-and-medicaid-services2023-07-06https://www.biodesix.com/terms2024-01-02https://www.biodesix.com/newsroom/press-releases/biodesix-to-present-at-2011-biotech-showcase2019-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-to-report-second-quarter-2022-financial-results-on-august-4-20222023-01-26https://www.biodesix.com/newsroom/press-releases/heinrich-roder-speak-6th-international-conference-bioinformatics-systems-biology2019-09-05https://www.biodesix.com/newsroom/news2023-08-29https://www.biodesix.com/newsroom/press-releases/biodesix-to-present-at-the-42nd-annual-william-blair-growth-stock-conference2022-06-01https://www.biodesix.com/wclc2020-abstract42021-01-21https://www.biodesix.com/newsroom/press-releases/biodesix-secures-10-million-in-series-b-1-funding2019-09-05https://www.biodesix.com/newsroom/press-releases/new-data-nodify-lung-nodule-risk-assessment-testing-chest-20212022-12-09https://www.biodesix.com/about/our-team/robin-harper-cowie2020-08-11https://www.biodesix.com/newsroom/press-releases/horizon-blue-cross-blue-shield-new-jersey-provides-coverage-biodesix-veristrat-test2019-09-05https://www.biodesix.com/newsroom/press-releases/independent-data-demonstrates-clinical-utility-biodesix-blood-based-tests2019-09-21https://www.biodesix.com/wclc2020-posters2021-02-11https://www.biodesix.com/newsroom/press-releases/prognostic-value-of-veristrat-testing-confirmed-in-phase-3-study-of-advanced-lung-cancer-patients2021-12-17https://www.biodesix.com/newsroom/press-releases/biodesix-announces-new-clinical-utility-evidence-for-the-nodify-xl2-nodule-risk-assessment-test-to-be-presented-at-ats-2023-international-conference2023-05-19https://www.biodesix.com/newsroom/press-releases/biodesix-appoints-franchi-massarany2020-07-19https://www.biodesix.com/newsroom/news/pathologist-tumor-profiling2020-11-13https://www.biodesix.com/newsroom/news/targeting-pharma-for-veristrat2021-12-17https://www.biodesix.com/newsroom/news/biodesix-secures-oncimmune2021-10-25https://www.biodesix.com/thank-you-blr2021-05-12https://www.biodesix.com/patients/covid-19/instruction-video2021-09-30https://www.biodesix.com/our-purpose2023-03-01https://www.biodesix.com/contact-nodify2021-06-16https://www.biodesix.com/newsroom/news/fierce-biotech-partnership2021-10-25https://www.biodesix.com/newsroom/press-releases/biodesix-present-study-data-blood-based-diagnostic-testing-pd-l12019-09-05https://www.biodesix.com/newsroom/press-releases/aacr-journal-biodesix-test-development-may-identify-melanoma-patients-benefit-checkpoint-inhibitors2020-11-16https://www.biodesix.com/technologies/machine-learning2021-05-13https://www.biodesix.com/newsroom/news/biodesix-cancer-treatment-rocky-radar2022-10-31https://www.biodesix.com/newsroom/news/future-droplet-digital-pcr2019-09-11https://www.biodesix.com/resources/enhanced-performance-of-the-nodify-xl2-blood-based-lung-nodule-test2021-04-07https://www.biodesix.com/newsroom/press-releases/biodesix-to-report-third-quarter-2023-financial-results-on-november-7-20232023-11-06https://www.biodesix.com/newsroom/blog/biodesix-biopharma-covid-192023-12-13https://www.biodesix.com/newsroom/events/msacl-20192019-09-12https://www.biodesix.com/newsroom/events-20232023-03-10https://www.biodesix.com/resources/providers/videos2023-04-11https://www.biodesix.com/newsroom/news/fast-lung-cancer-diagnosis-saves-lives2021-12-17https://www.biodesix.com/newsroom/press-releases/first-system-wide-integration2019-11-05https://www.biodesix.com/newsroom/press-releases/veristrat-data-to-be-presented-at-2012-chicago-multidisciplinary-symposium-in-thoracic-oncology2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-adds-dr-charles-watts-to-board-of-directors2019-12-09https://www.biodesix.com/newsroom/press-releases/pipeline-test-shows-utility-triaging-patients-with-lung-nodules-chest-data-publication2020-11-16https://www.biodesix.com/newsroom/blog/lung-cancer-screening-nodule-programs-spotlight-series-dr.-dragos-zanchi-and-pulmonary-sleep-of-tampa-bay2023-12-06https://www.biodesix.com/newsroom/blog/test-help-identify-benign-lung-nodules2021-11-22https://www.biodesix.com/conference2021-06-02https://www.biodesix.com/newsroom/press-releases/biodesix-publishes-data-on-new-covid-19-artificial-intelligence-ai-based-algorithm-for-use-in-clinical-decision-support-systems2021-02-09https://www.biodesix.com/newsroom/press-releases/biodesix-announces-intent-to-launch-liquid-biopsy-next-generation-sequencing-test-with-unprecedented-turnaround-time2021-04-29https://www.biodesix.com/nodule-patient-resources2023-12-11https://www.biodesix.com/newsroom/press-releases/biodesix-to-present-data-on-blood-based-diagnostic-tests-for-patients-with-nsclc2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-releases-new-data-at-aacr-on-proteomic-profiling2021-04-12https://www.biodesix.com/biopharma-services/clinical-trial-support2022-04-13https://www.biodesix.com/resources/4-30-20-webinar2020-05-13https://www.biodesix.com/our-purpose/our-team/scott-hutton2023-12-12https://www.biodesix.com/resources/providers/reimbursement2023-02-27https://www.biodesix.com/newsroom/press-releases/nivolumab-test-biodesix2019-12-09https://www.biodesix.com/newsroom/events2023-11-09https://www.biodesix.com/newsroom/press-releases/biodesix-bio-rad-covid-192020-03-20https://www.biodesix.com/newsroom/news/testing-lung-cancer-outcomes2021-10-25https://www.biodesix.com/newsroom/press-releases/biodesix-announces-two-presentations-on-lung-cancer-treatment-guidance-tests-at-the-iaslc-2023-world-lung-conference-on-lung-cancer2023-09-07https://www.biodesix.com/newsroom/press-releases/biodesix-ceo-scott-hutton-selected-as-one-of-top-25-biotech-ceos-of-20212021-02-25https://www.biodesix.com/newsroom/press-releases/biodesix-to-showcase-new-data-on-patient-immune-profiling-from-multiple-studies-at-world-lung-conference2021-01-26https://www.biodesix.com/newsroom/press-releases/media-advisory-dr-heinrich-roder-biodesix-cto-speak-precision-medicine-world-conference2022-10-31https://www.biodesix.com/newsroom/news/clinical-omics2021-10-25https://www.biodesix.com/newsroom/press-releases/biodesix-streck-partnership2022-12-09https://www.biodesix.com/contact-beacon2021-06-16https://www.biodesix.com/newsroom/press-releases/biodesix-announces-proposed-public-offering-of-common-stock2022-11-17https://www.biodesix.com/newsroom/press-releases/disease-state-trial-options-patients-advanced-nsclc-automated-manual-workflows-cfdna-extraction2020-11-16https://www.biodesix.com/newsroom/news/aveo-biodesix-esmo-20142023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-announces-veristrat-data-in-head-and-neck-cancer-to-be-presented-at-asco2021-11-22https://www.biodesix.com/newsroom/press-releases/biodesix-announces-fourth-quarter-2020-results-12022-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-announces-second-quarter-2022-results-and-highlights2022-08-11https://www.biodesix.com/newsroom/blog/infographic-what-is-a-lung-nodule2021-11-23https://www.biodesix.com/our-purpose/our-team/kieran-okane2023-12-12https://www.biodesix.com/newsroom/events/biomarker-cdx-20202020-02-05https://www.biodesix.com/newsroom/press-releases/biodesix-awarded-u.s.-federal-supply-schedule-contract-for-its-comprehensive-lung-cancer-diagnostic-testing-solutions2022-10-17https://www.biodesix.com/contact/thank-you2021-05-12https://www.biodesix.com/newsroom/press-releases/biodesix-completes-series-c-financing-and-receives-grant2019-09-05https://www.biodesix.com/contact-download-biopharma2021-06-16https://www.biodesix.com/biopharma-services/discovery-feasibility2022-04-20https://www.biodesix.com/newsroom/blog/pulmonologists-respond-to-covid-192021-11-22https://www.biodesix.com/about/our-team/kieran-o-kane2020-08-11https://www.biodesix.com/pillar-demo2020-02-19https://www.biodesix.com/patients/how-we-help2023-06-26https://www.biodesix.com/newsroom/news/lung-cancer-immune-blockade2023-12-12https://www.biodesix.com/resources/garwood-webinar2019-11-01https://www.biodesix.com/newsroom/press-releases/biodesix-supports-unique-lung-cancer-research-initiative-castle-study-enrolls-initial-subjects2019-09-05https://www.biodesix.com/newsroom/press-releases/biodesix-series-d-financing2022-10-28https://www.biodesix.com/newsroom/press-releases/biodesix-proteomic-analysis-presented-at-esmo-world-congress2022-12-07https://www.biodesix.com/newsroom/news/veristrat-positive-coverage-decisions2020-11-13https://www.biodesix.com/newsroom/news/lung-cancer-breakthroughs2021-12-17https://www.biodesix.com/nodifylung/case-study-video2021-05-12https://www.biodesix.com/cpass2021-06-16https://www.biodesix.com/newsroom/events/io360-20202020-02-07https://www.biodesix.com/newsroom/press-releases/biodesix-completes-enrollment-of-insight-study-assessing-clinical-utility-of-the-veristrat-blood-based-host-immune-classifier2023-06-27https://www.biodesix.com/our-purpose/our-team/brianna-phillips2023-12-12https://www.biodesix.com/newsroom/press-releases/preliminary-private-payor-rate-based-payment-amounts2020-11-13https://www.biodesix.com/our-purpose/our-team/robin-harper-cowie2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-begins-covid-testing2022-12-09https://www.biodesix.com/resources/webinar-replay-pritchett-20202020-06-19https://www.biodesix.com/newsroom/press-releases/biodesixs-diagnostic-cortex-platform-used-three-studies-presented-sitc2019-12-09https://www.biodesix.com/newsroom/press-releases/veristrat-test-cost-saving-improves-survival-quality-life-advanced-lung-cancer-patients2022-10-31https://www.biodesix.com/newsroom/press-releases/biodesix-receives-positive-coverage-from-cigna-for-veristrat-test2022-10-31https://www.biodesix.com/thank-you-biopharma2021-09-20https://www.biodesix.com/newsroom/press-releases/biodesix-ranked-top-proteomics-solutions-company-by-life-sciences-review-magazine2022-12-12https://www.biodesix.com/contact-cancer-cant-wait2021-06-16https://www.biodesix.com/careers/current-openings2023-01-13https://www.biodesix.com/newsroom/press-releases/biodesix-to-participate-in-two-upcoming-investor-conferences-in-november2023-12-13https://www.biodesix.com/newsroom/press-releases/biodesix-advances-personalized-medicine-with-veristrat2020-11-13https://www.biodesix.com/newsroom/press-releases/next-generation-sequencing-assay-for-blood-based-companion-diagnostic-solutions-in-cancer2021-12-17https://www.biodesix.com/covid-19-testing/individuals2022-04-13https://www.biodesix.com/newsroom/press-releases/biodesix-progenetics-announce-distribution-agreement-israel2019-09-05https://www.biodesix.com/newsroom/press-releases/biodesix-named-company-year-cba2019-12-09https://www.biodesix.com/biopharma-services2023-03-15https://www.biodesix.com/newsroom/press-releases/biodesix-appoints-scott-hutton2019-11-05https://www.biodesix.com/newsroom/press-releases/aveo-and-biodesix-ficlatuzumab-with-a-companion-diagnostic-for-treatment-of-nsclc2020-11-16https://www.biodesix.com/products/covid-testing/symptom-checker2020-06-16https://www.biodesix.com/newsroom/news/multivariate-blood-test-cancer-outcomes2021-10-25https://www.biodesix.com/newsroom/press-releases/insight-study-interim-data2022-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-acquires-integrated-diagnostics2021-11-22https://www.biodesix.com/newsroom/press-releases/clin-tof-successfully-integrated-veristrat-workflow2019-12-09https://www.biodesix.com/newsroom/events/io-360-20192019-09-12https://www.biodesix.com/careers2022-10-21https://www.biodesix.com/newsroom/blog/action-beyond-awareness-the-imperative-of-actionable-early-detection-in-lung-cancer-care2023-12-13https://www.biodesix.com/newsroom/press-releases/biodesix-heinrich-roder-presents-at-2013-biomarker-summit2019-09-21https://www.biodesix.com/newsroom/press-releases/humana-mutualoh-preferredone-coverage2022-10-28https://www.biodesix.com/newsroom/press-releases/biodesix-enhances-access-to-nodify-lung-testing-with-launch-of-new-blood-draw-method2023-12-13https://www.biodesix.com/newsroom/press-releases/wellmark-bcbs-iowa-south-dakota-provides-coverage-veristrat-test2019-12-09https://www.biodesix.com/newsroom/news/biodesix-216-of-the-inc-500-for-20152021-09-29https://www.biodesix.com/newsroom/press-releases/results-first-prospective-biomarker-stratified-validation-study-in-oncology2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference2023-01-26https://www.biodesix.com/newsroom/news/biodesix-new-immunotherapy-test2023-12-12https://www.biodesix.com/newsroom/events/asco-sitc-20192019-09-12https://www.biodesix.com/newsroom/press-releases/biodesix-tests-show-promise-in-patient-selection-for-immunotherapy2019-09-21https://www.biodesix.com/newsroom/press-releases/canaccord-genuity-42nd-annual-growth-conference2022-08-11https://www.biodesix.com/newsroom/press-releases/hibercell-and-biodesix-initiate-broad-collaboration-for-companion-diagnostic-discovery-development-and-commercialization2021-01-13https://www.biodesix.com/services/investigator-research2021-09-17https://www.biodesix.com/newsroom/press-releases/veristrat-patients-squamous-cell-carcinoma-lung-likely-improved-survival-afatinib-therapy2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-to-present-data-at-iaslc-2022-world-conference2023-01-26https://www.biodesix.com/patients/friends-family-covid-testing2020-08-25https://www.biodesix.com/webinar-genentech2020-10-21https://www.biodesix.com/newsroom/news/nsclc-utility-and-challenges2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-bigten2020-10-02https://www.biodesix.com/newsroom/news/european-lung-cancer-conference2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-covid-19-testing-colorado-state-university2020-11-13https://www.biodesix.com/newsroom/press-releases/alcmi-biodesix-initiate-study2021-12-17https://www.biodesix.com/newsroom/press-releases/phase-iii-lung-cancer-trial-show-veristrat-identifies-patients-likely-to-respond-to-erlotinib2020-11-16https://www.biodesix.com/newsroom/press-releases/genestrat-liquid-biopsy-testing-now-includes-ros1-ret-mutations2019-09-05https://www.biodesix.com/newsroom/media-kit2023-11-09https://www.biodesix.com/newsroom/events/4th-asia-pacific-droplet-digital-pcr-symposium-20192019-09-12https://www.biodesix.com/our-purpose/our-team2024-03-27https://www.biodesix.com/thank-you-poster2021-05-24https://www.biodesix.com/lung-diagnostics/covid-19-testing/healthcare-providers2020-10-01https://www.biodesix.com/newsroom/press-releases/blood-based-testing-pd-l1-detection-concordance-immunohistochemistry2019-09-05https://www.biodesix.com/newsroom/press-releases/veristrat-test-predicts-outcomes-in-advanced-breast-cancer-patients2019-09-05https://www.biodesix.com/newsroom/press-releases/biodesix-positive-bioscience-announce-partnership-bring-cancer-tests-india2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-announces-phase-3-clinical-trial-collaboration-with-kadmon2019-09-05https://www.biodesix.com/newsroom/press-releases/biodesix-to-present-at-leerink-partners-5th-annual-global-healthcare-conference2019-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-to-participate-in-two-upcoming-investor-conferences-in-september2022-09-06https://www.biodesix.com/newsroom/news/personalized-medicine-coalition-iaslcesmo-elcc2021-12-17https://www.biodesix.com/newsroom/news/lung-cancer-science-daily2021-11-22https://www.biodesix.com/newsroom/press-releases/biodesix-new-commercial-org2023-12-13https://www.biodesix.com/resources/providers/case-studies2023-10-17https://www.biodesix.com/newsroom/press-releases/biodesix-to-participate-at-cowens-43rd-annual-healthcare-conference2023-03-01https://www.biodesix.com/newsroom/press-releases/aetna-provides-coverage-for-biodesix-veristrat-test2019-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-hires-ryan-siurek2021-09-29https://www.biodesix.com/newsroom/press-releases/biodesix-announces-first-quarter-2023-results-and-highlights2023-06-20https://www.biodesix.com/newsroom/press-releases/third-quarter-2021-financial-results-report-nov-15-20212022-12-09https://www.biodesix.com/resources/cpass-webinar-12021-05-07https://www.biodesix.com/newsroom/blog/nodify-xl2-relieves-patient-anxiety2021-10-25https://www.biodesix.com/careers/leadership2020-08-13https://www.biodesix.com/newsroom/press-releases/biodesix-raises-additional-series-e-financing2019-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-presents-cell-free-dna-process-optimization-liquid-biopsy-test2019-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-closes-series-e-financing2019-09-05https://www.biodesix.com/newsroom/press-releases/biodesix-named-to-inc-5005000-fastest-growing-private-companies-list2021-09-29https://www.biodesix.com/newsroom/press-releases/norgen-biotek-agreement-with-biodesix-enables-eml4-alk-liquid-biopsy-test-with-72-hour-results2020-11-16https://www.biodesix.com/our-purpose/our-team/steve-springmeyer-md2023-12-12https://www.biodesix.com/our-purpose/our-team/robbie-lunt2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-advances-oracle-registry-for-lung-nodule-cancer-test2019-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-announces-issuance-of-two-u.s.-patents-expands-coverage-of-diagnostic-methods-to-improve-care-for-cancer-patients2021-12-17https://www.biodesix.com/newsroom/press-releases/jon-faiz-kayyem-board-of-directors2022-12-09https://www.biodesix.com/newsroom/press-releases/veristrat-ids-patients-for-afatanib-therapy2022-10-28https://www.biodesix.com/newsroom/blog/diagnostic-solutions-for-biopharma-covid-19-clinical-trials2021-02-10https://www.biodesix.com/newsroom/press-releases/addon-series-g-enters-debt-refinancing-agreement-scott-hutton2022-10-31https://www.biodesix.com/newsroom/press-releases/society-for-advanced-bronchoscopy-commits-to-excellence-as-demand-increases2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-announces-second-quarter-2023-results-and-highlights2023-08-09https://www.biodesix.com/newsroom/press-releases/biodesix-bioyong-to-develop-veristrat-test-china2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-selected-as-a-colorado-company-to-watch2019-09-05https://www.biodesix.com/newsroom/press-releases/biodesix-ceo-scott-hutton-named-to-the-healthcare-technology-reports-list-of-top-25-biotech-ceos-in-20222023-12-13https://www.biodesix.com/newsroom/press-releases/biodesix-to-announce-results-of-veristrat-biomarker-study2019-09-05https://www.biodesix.com/newsroom/press-releases/lung-cancer-journal-veristrat-proteomic-test-improves-survival-decreases-costs-advanced-nsclc2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-partners-with-datavant-to-enhance-value-of-lung-cancer-databank2022-10-31https://www.biodesix.com/webinar-recording-ctdna2020-08-28https://www.biodesix.com/resources/webinar-replay-silvestri2020-05-28https://www.biodesix.com/newsroom/press-releases/biodesix-to-report-first-quarter-20212022-12-09https://www.biodesix.com/search2019-12-06https://www.biodesix.com/newsroom/press-releases2023-11-09https://www.biodesix.com/newsroom/press-releases/veristrat-changes-treatment-decisions-lung-cancer-patients-reduces-treatment-end-life2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-adds-to-series-e-financing2019-09-05https://www.biodesix.com/newsroom/press-releases/aveo-and-biodesix-present-veristrat-patient-analysis-at-esm2022-10-28https://www.biodesix.com/newsroom/news/burrill-report2023-12-12https://www.biodesix.com/newsroom/press-releases/veristrat-results-correlate-with-survival-outcomes-in-kidney-cancer-patients2019-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-announces-appointment-of-lawrence-lair-t.-kennedy-jr.-to-board-of-directors2023-01-31https://www.biodesix.com/newsroom/press-releases/biodesix-announces-fourth-quarter-2020-results2021-12-17https://www.biodesix.com/newsroom/news/biodesix-pipeline-test-lung-nodules2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-to-participate-in-william-blairs-43rd-annual-growth-stock-conference2023-12-13https://www.biodesix.com/newsroom/press-releases/biodesix-announces-first-quarter-2022-results-and-highlights2023-01-26https://www.biodesix.com/patients/covid-19/csu-video2020-08-06https://www.biodesix.com/resources/io360-2021-replay2021-03-16https://www.biodesix.com/newsroom/press-releases/biodesix-announces-three-abstracts-to-be-presented-at-asco-2023-annual-meeting2023-06-01https://www.biodesix.com/newsroom/press-releases/douglas-e-swan-named-vice-president-commercial-operations2020-11-16https://www.biodesix.com/order-test-kit/thank-you2021-05-12https://www.biodesix.com/newsroom/press-releases/biodesix-to-work-with-concentra-and-hooper-holmes-to-expand-access-to-veristrat2019-09-05https://www.biodesix.com/newsroom/press-releases/biodesix-announces-receipt-of-clia-registration-number2021-12-17https://www.biodesix.com/newsroom/press-releases/biodesix-to-acquire-oncimmune-in-the-united-states2022-12-07https://www.biodesix.com/services/investigator-research/clinical-studies2021-09-17https://www.biodesix.com/newsroom/news/new-study-veristrat2023-12-13https://www.biodesix.com/contact-blr-brochure2021-06-16https://www.biodesix.com/our-tests/iq-lung2024-01-16https://www.biodesix.com/newsroom/press-releases/veristrat-epidermal-growth-factor-receptor-mutation-status-study-world-conference-on-lung-cancer2020-11-16https://www.biodesix.com/contact-worksafe2021-06-16https://www.biodesix.com/newsroom/press-releases/biodesix-completes-series-f-financing2019-12-09https://www.biodesix.com/newsroom/blog2023-11-09https://www.biodesix.com/nodifylung/video-how-nodify-works2021-05-12https://www.biodesix.com/newsroom/press-releases/biodesix-announces-publication-of-the-oracle-clinical-utility-study-with-the-primary-endpoint-demonstrating-that-the-nodify-xl2-test-redu-16891685427502023-12-13https://www.biodesix.com/newsroom/press-releases/scott-hutton-of-biodesix-selected-as-usa-chief-executive-officer-of-the-year-by-ceo-monthly-magazine2021-02-02https://www.biodesix.com/ats20212021-05-10https://www.biodesix.com/newsroom/press-releases/biodesix-receives-carefirst-bluecross-blueshield-bcbs-coverage-for-veristrat-test2021-09-29https://www.biodesix.com/newsroom/news/oncology-times-liquid-biopsies-nsclc2020-11-13https://www.biodesix.com/newsroom/press-releases/biodesix-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-march-16-20212021-03-09https://www.biodesix.com/our-purpose/our-team/mark-deblock2023-12-12https://www.biodesix.com/our-purpose/our-team/gary-pestano-phd2023-12-12https://www.biodesix.com/newsroom/press-releases/biodesix-announces-research-agreement-with-top-us-cancer-center2022-06-03https://www.biodesix.com/newsroom/press-releases/biodesix-receives-new-eu-and-us-patents-for-blood-based-oncology-tests2019-12-09https://www.biodesix.com/newsroom/news/biodesix-assay-genetic-engineering-news2023-12-12https://www.biodesix.com/newsroom/press-releases/aveo-oncology-biodesix2022-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-highlights-pipeline-and-companion-diagnostic-development-02019-12-09https://www.biodesix.com/newsroom/news/cgtv-story-biodesix-bioyong-watch-video2019-12-09https://www.biodesix.com/newsroom/press-releases/aveo-oncology-biodesix-cyfi-2-study2019-11-07https://www.biodesix.com/covid-19-testing/employers2022-04-13https://www.biodesix.com/nodifylung/video-ats2020-pritchett2021-05-12https://www.biodesix.com/newsroom/press-releases/biodesix-to-present-at-bioconference-live-innovative-online-conference2019-12-09https://www.biodesix.com/contact-biopharma-brochure2021-06-16https://www.biodesix.com/newsroom/press-releases/biodesix-announces-commercial-availability-of-sars-cov-2-neutralization-antibody-test2021-10-25https://www.biodesix.com/newsroom/press-releases/william-blair-41st-annual-growth-stock-conference2022-12-09https://www.biodesix.com/thank-you-abstract-utilizing-serum2021-05-12https://www.biodesix.com/newsroom/press-releases/biodesix-obtains-medicare-coverage-for-nodify-cdt-lung-nodule-test2022-06-07https://www.biodesix.com/newsroom/press-releases/veristrat-data-demonstrate-independent-prediction-of-immunotherapy-outcomes-for-nsclc-patients2020-11-16https://www.biodesix.com/newsroom/press-releases/interim-results-study-indicate-veristrat-testing-impacts-treatment-decisions-across-stages-nsclc2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-announces-first-quarter-2021-results2022-12-09https://www.biodesix.com2023-11-09https://www.biodesix.com/newsroom/press-releases/study-confirms-veristrat-test-helps-physicians-manage-lung-cancer-patients2020-11-17https://www.biodesix.com/newsroom/press-releases/health-net-inc-provides-coverage-for-biodesix-veristrat-test2022-10-31https://www.biodesix.com/newsroom/press-releases/spesana-partnership2022-12-09https://www.biodesix.com/newsroom/press-releases/philips-incorporates-biodesix-blood-based-proteomic-nodule-risk-assessment-testing-into-lung-cancer-orchestrator-to-advance-early-lung-ca-16565322381992022-06-30https://www.biodesix.com/newsroom/press-releases/biodesix-ipo2020-10-28https://www.biodesix.com/newsroom/press-releases/biodesix-announces-four-presentations-of-health-economic-data-highlighting-cost-saving-potential-of-nodify-lung-testing2023-12-13https://www.biodesix.com/newsroom/press-releases/biodesix-presents-new-data-from-the-insight-study-at-the-2022-society-for-immunotherapy-of-cancer-sitc-37th-annual-meeting2022-11-10https://www.biodesix.com/patients/diagnostic-solutions2023-09-27https://www.biodesix.com/newsroom/press-releases/positive-data-in-detection-of-primary-immunotherapy-resistance-to-anti-pd-1-therapy-in-nsclc2020-11-16https://www.biodesix.com/resources/webinar-replay-akerley2020-06-04https://www.biodesix.com/newsroom/press-releases/genestrat-blood-based-mutation-test-eml4-alk-fusions2022-10-31https://www.biodesix.com/newsroom/press-releases/biodesix-immodulon-collaborating-on-pancreatic-cancer-biomarkers2019-12-09https://www.biodesix.com/biopharma-services/commercialization2022-12-07https://www.biodesix.com/privacy-policy-hipaa2024-03-18https://www.biodesix.com/newsroom/press-releases/biodesix-closes-series-d-financing-32022-10-28https://www.biodesix.com/newsroom/press-releases/veristrat-testing-predicts-survival-in-advanced-nsclc-and-immunotherapy2022-12-09https://www.biodesix.com/newsroom/press-releases/presentation-sitc-testing-methodology-may-identify-primary-immunotherapy-resistance-patients2022-10-31https://www.biodesix.com/resources/webinar-replay-4-30-202020-05-11https://www.biodesix.com/mtcs20212021-09-28https://www.biodesix.com/newsroom/press-releases/biodesix-leaders-share-commercial-pipeline-updates-annual-qpcr-dpcr-congress2022-10-31https://www.biodesix.com/newsroom/press-releases/present-data-supporting-proteomic-based-immunotherapy-diagnostic-tests-ai-explainability-diagnostic-tests2022-12-09https://www.biodesix.com/newsroom/press-releases/biodesix-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-6-20232023-12-13https://www.biodesix.com/newsroom/press-releases/three-studies-chest2021-12-17https://www.biodesix.com/newsroom/press-releases/veristrat-outcomes-data-to-be-presented-at-iaslcesmo-lung-cancer-conference2020-11-16https://www.biodesix.com/newsroom/covid-news2021-05-20https://www.biodesix.com/newsroom/blog/talking-to-your-doctor-about-lung-nodules-or-lung-screening-a-comprehensive-guide2023-12-15https://www.biodesix.com/newsroom/press-releases/veristrat-t790m-mutated-advanced-nsclc-patients-likely-improved-progression-free-survival-third-generation2020-11-16https://www.biodesix.com/newsroom/press-releases/biodesix-announces-inclusion-of-veristrat-in-updated-nccn-guidelines2019-09-05https://www.biodesix.com/services/clinical-trials2020-09-21https://www.biodesix.com/contact-bd2021-06-16https://www.biodesix.com/newsroom/press-releases/mrm-proteomics-and-biodesix-partner-to-develop-precision-lung-cancer-diagnostics2023-01-26https://www.biodesix.com/newsroom/press-releases/third-quarter-2021-financial-results-highlights2022-12-09https://www.biodesix.com/resources/nodify-collection-video2020-02-18https://www.biodesix.com/resources/providers/certifications2024-03-26https://www.biodesix.com/nodify-xl2-collection-video2021-09-17https://www.biodesix.com/newsroom/news/tests-stratify-immunotherapy-patients2022-10-31https://www.biodesix.com/newsroom/press-releases/biodesix-announces-third-quarter-2023-results-and-highlights2023-12-21https://www.biodesix.com/newsroom/press-releases/biodesix-relocates-to-boulder-co2019-09-05https://www.biodesix.com/newsroom/press-releases/innovative-company-2016-award2023-01-31https://www.biodesix.com/newsroom/press-releases/study-results-biodesixs-immunotherapy-test-will-presented-dr-jeffrey-weber2019-09-05https://www.biodesix.com/newsroom/press-releases/biodesix-announces-first-four-private-payer-coverage-policies-for-the-nodify-xl2-test2023-01-31https://www.biodesix.com/newsroom/press-releases/biodesix-to-present-data-at-the-chest-2022-annual-meeting2023-01-26https://www.biodesix.com/newsroom/press-releases/prose-study-lancet-oncology2021-09-29https://www.biodesix.com/newsroom/press-releases/new-veristrat-data-san-antonio-breast-cancer-symposium2020-11-13https://www.biodesix.com/newsroom/press-releases/biodesix-completes-acquisition-oncimmune2019-11-05https://www.biodesix.com/patients/covid-19/carroll2020-08-06https://www.biodesix.com/newsroom/press-releases/biodesix-receives-certification-from-ny-state2019-09-05https://www.biodesix.com/about/our-team/gary-pestano2020-08-11https://www.biodesix.com/thank-you-abstract36002021-05-12https://www.biodesix.com/newsroom/press-releases/biodesix-to-present-at-world-cdx2019-09-05https://www.biodesix.com/resources/publications2022-12-07https://www.biodesix.com/newsroom/events/amp-global-20192019-09-12https://www.biodesix.com/resources/research/studies2024-03-19https://www.biodesix.com/newsroom/press-releases/biodesix-announces-presentation-on-use-of-biomarker-based-risk-assessment-to-inform-lung-nodule-management2021-09-29https://www.biodesix.com/newsroom/press-releases/biodesix-named-a-top-100-healthcare-technology-company-of-20222022-08-09https://www.biodesix.com/contact-cdma2021-06-16https://www.biodesix.com/order-a-test2024-02-08